600285.SS
Henan Lingrui Pharmaceutical Co., Ltd.
ShanghaiCNYEQUITY
Healthcare
DELAYED
Last price
19.55
▼ 0.24 (1.21%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
19.71
Prev close
19.79
Day high
19.73
Day low
19.35
Volume
8.72M
Market cap
$11.08B
P/E (TTM)
14.16
52W range
19.00 – 24.29
Day trading desk
Gap from prior close
-0.40%
Prior close 19.79
VWAP
19.48
+0.34% from price
Relative volume
0.78×
Normal
Session range
1.81%
19.36 – 19.71
Position in range
54%
Mid range
ATR (14D)
0.61
3.11% of price
Prior day high
20.16
PDH
Prior day low
19.78
PDL
Bid / ask spread
—
Quote not published
Session volume
8.14M
Avg 10.45M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-0.81%
+0.6%
1M
-13.58%
-17.3%
3M
-7.96%
-11.1%
6M
-10.98%
-22.0%
YTD
-5.65%
-17.9%
1Y
-15.15%
-35.2%
3Y
+29.75%
-44.4%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on 600285.SS open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
136.23M
Total on file
Fundamentals
Market cap$11.08B
Enterprise value$9.97B
Revenue (TTM)$3.90B
Gross profit$3.07B
EBITDA$949.62M
Net income$780.21M
EPS (TTM)$1.38
Free cash flow$670.80M
Total cash$1.57B
Total debt$420.68M
Book value / share$5.70
Shares outstanding567.12M
Float434.32M
Short % of float—
Dividend yield5.63%
Beta (5Y)-0.01
Valuation & profitability ratios
Trailing P/E14.16
Forward P/E13.03
PEG ratio—
Price / sales—
Price / book3.43
EV / revenue2.56
EV / EBITDA10.50
Gross margin78.63%
Operating margin27.03%
Profit margin19.99%
Return on equity24.63%
Return on assets9.42%
Debt / equity12.87
Current ratio1.18
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $3.85B | $3.50B | $3.31B | $3.00B | +10.1% |
| Operating revenue | $3.85B | $3.50B | $3.31B | $3.00B | +10.1% |
| Cost of revenue | $769.55M | $846.56M | $884.39M | $832.11M | -9.1% |
| Gross profit | $3.08B | $2.65B | $2.43B | $2.17B | +16.2% |
| Research & development | $169.12M | $131.53M | $109.65M | $125.07M | +28.6% |
| Selling, general & admin | $1.71B | $1.48B | $1.37B | $1.35B | +16.0% |
| Total operating expense | $2.25B | $1.90B | $1.82B | $1.74B | +18.4% |
| Operating income | $838.46M | $757.42M | $609.68M | $429.61M | +10.7% |
| Net interest income | $5.10M | $18.89M | $35.13M | $26.59M | -73.0% |
| Pre-tax income | $879.47M | $827.57M | $653.04M | $517.03M | +6.3% |
| Tax provision | $117.02M | $104.99M | $84.93M | $51.73M | +11.5% |
| Net income | $759.50M | $722.55M | $568.11M | $465.30M | +5.1% |
| Net income to common | $759.50M | $722.55M | $568.11M | $465.30M | +5.1% |
| Basic EPS | 1.34 | 1.29 | 1.01 | 0.84 | +4.1% |
| Diluted EPS | 1.34 | 1.28 | 1.00 | 0.82 | +4.4% |
| EBIT | $883.37M | $826.81M | $652.86M | $517.81M | +6.8% |
| EBITDA | $981.94M | $900.35M | $730.49M | $594.06M | +9.1% |
| Basic shares | 566.79M | 561.42M | 561.37M | 556.58M | +1.0% |
| Diluted shares | 567.64M | 564.05M | 566.41M | 568.14M | +0.6% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $382.84M | $1.23B | $1.50B | $1.18B | -68.8% |
| Cash & short-term investments | $543.20M | $1.23B | $1.50B | $1.33B | -55.8% |
| Accounts receivable | $430.40M | $319.37M | $258.40M | $195.97M | +34.8% |
| Inventory | $436.64M | $434.97M | $467.35M | $486.41M | +0.4% |
| Total current assets | $2.28B | $2.46B | $2.60B | $2.51B | -7.2% |
| Property, plant & equipment | $682.62M | $631.20M | $647.81M | $706.76M | +8.1% |
| Goodwill & intangibles | $825.18M | $209.15M | $229.84M | $241.87M | +294.5% |
| Total assets | $5.64B | $5.02B | $4.77B | $4.34B | +12.3% |
| Total current liabilities | $2.12B | $1.87B | $1.90B | $1.71B | +12.9% |
| Current debt | $391.65M | $33.27M | $141.22M | $93.81M | +1,077.0% |
| Total debt | $398.51M | $41.60M | $149.27M | $101.23M | +857.9% |
| Total liabilities | $2.20B | $1.94B | $1.97B | $1.79B | +13.6% |
| Retained earnings | $2.15B | $1.90B | $1.61B | $1.38B | +13.6% |
| Shareholder equity | $3.40B | $3.07B | $2.79B | $2.55B | +10.7% |
| Working capital | $164.31M | $583.70M | $698.77M | $796.44M | -71.9% |
| Net tangible assets | $2.58B | $2.86B | $2.56B | $2.31B | -10.1% |
| Shares issued | 567.12M | 567.12M | 567.14M | 567.46M | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $762.45M | $722.58M | $568.12M | $465.30M | +5.5% |
| Depreciation & amortisation | $98.58M | $73.54M | $77.62M | $76.25M | +34.0% |
| Change in working capital | -$302.77M | $101.49M | $158.07M | $309.60M | -398.3% |
| Operating cash flow | $553.88M | $875.86M | $813.43M | $834.91M | -36.8% |
| Capital expenditure | -$56.83M | -$115.11M | -$21.20M | -$26.99M | +50.6% |
| Investing cash flow | -$1.19B | -$665.83M | -$229.70M | -$83.81M | -78.1% |
| Dividends paid | -$511.29M | -$451.34M | -$344.28M | -$288.84M | -13.3% |
| Financing cash flow | -$213.26M | -$471.94M | -$272.73M | -$373.09M | +54.8% |
| Free cash flow | $497.05M | $760.75M | $792.23M | $807.92M | -34.7% |
| End cash position | $382.84M | $1.23B | $1.49B | $1.18B | -68.8% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $1.13B | $812.03M | $1.08B | $1.02B | $741.72M | +38.7% |
| Operating revenue | $1.13B | $812.03M | $1.08B | $1.02B | $741.72M | +38.7% |
| Cost of revenue | $245.62M | $192.25M | $154.82M | $237.15M | $156.85M | +27.8% |
| Gross profit | $880.45M | $619.78M | $923.63M | $783.61M | $584.87M | +42.1% |
| Research & development | $31.48M | $64.52M | $40.26M | $22.80M | $57.04M | -51.2% |
| Selling, general & admin | $563.59M | $99.17M | $433.49M | $508.38M | $130.88M | +468.3% |
| Total operating expense | $604.56M | $501.99M | $639.13M | $541.19M | $461.64M | +20.4% |
| Operating income | $275.89M | $117.79M | $284.50M | $242.42M | $123.23M | +134.2% |
| Net interest income | $6.10M | -$10.16K | $2.05M | $2.10M | $5.69M | +60,190.0% |
| Pre-tax income | $285.51M | $121.91M | $297.88M | $253.67M | $162.47M | +134.2% |
| Tax provision | $38.07M | $13.00M | $38.74M | $36.94M | $13.79M | +192.9% |
| Net income | $246.33M | $108.57M | $257.57M | $216.82M | $148.68M | +126.9% |
| Net income to common | $246.33M | $108.57M | $257.57M | $216.82M | $148.68M | +126.9% |
| Basic EPS | 0.44 | — | — | 0.38 | — | — |
| Diluted EPS | 0.43 | — | — | 0.38 | — | — |
| EBIT | $286.28M | $122.55M | $298.82M | $254.18M | $161.20M | +133.6% |
| EBITDA | $286.28M | $122.55M | $298.82M | $254.18M | $161.20M | +133.6% |
| Basic shares | 566.28M | — | — | 566.10M | — | — |
| Diluted shares | 567.59M | — | — | 567.59M | — | — |
| Line item | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $452.89M | $382.84M | $532.32M | $570.93M | $1.23B | +18.3% |
| Cash & short-term investments | $743.76M | $543.20M | $592.86M | $570.93M | $1.23B | +36.9% |
| Accounts receivable | $551.01M | $430.40M | $493.10M | $433.34M | $319.37M | +28.0% |
| Inventory | $392.61M | $436.64M | $411.85M | $384.42M | $434.97M | -10.1% |
| Total current assets | $2.57B | $2.28B | $2.35B | $2.00B | $2.46B | +12.6% |
| Property, plant & equipment | $668.78M | $682.62M | $708.16M | $707.13M | $631.20M | -2.0% |
| Goodwill & intangibles | $818.95M | $825.18M | $834.96M | $844.79M | $209.15M | -0.8% |
| Total assets | $5.97B | $5.64B | $5.57B | $5.41B | $5.02B | +5.9% |
| Total current liabilities | $2.19B | $2.12B | $2.39B | $1.99B | $1.87B | +3.6% |
| Current debt | $274.63M | $391.65M | $456.67M | $81.36M | $33.27M | -29.9% |
| Total debt | $281.00M | $398.51M | $464.16M | $89.00M | $41.60M | -29.5% |
| Total liabilities | $2.28B | $2.20B | $2.47B | $2.07B | $1.94B | +3.7% |
| Retained earnings | $2.40B | $2.15B | $1.87B | $2.12B | $1.90B | +11.4% |
| Working capital | $375.24M | $164.31M | -$47.36M | $18.30M | $583.70M | +128.4% |
| Net tangible assets | $2.83B | $2.58B | $2.23B | $2.47B | $2.86B | +9.9% |
| Shares issued | 567.12M | 567.12M | 567.12M | 567.12M | 567.12M | 0.0% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|
| Capital expenditure | -$13.13M | -$18.60M | -$20.87M | -$11.74M | -$81.50M | +29.4% |
| Investing cash flow | -$98.61M | $8.16M | -$142.89M | -$785.77M | -$48.33M | -1,309.1% |
| Dividends paid | -$53.75K | -$947.01K | -$509.57M | -$414.61K | -$2.66M | +94.3% |
| Financing cash flow | -$99.78M | -$148.46M | -$133.69M | $10.72M | -$21.55M | +32.8% |
| Free cash flow | $255.32M | $44.89M | $217.10M | $105.87M | $444.32M | +468.8% |
| End cash position | $452.89M | $382.84M | $532.32M | $570.93M | $1.23B | +18.3% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | 1.50 | 1 | $4.03B | +4.7% |
| Next year | 1.50 | 1 | $4.36B | +8.1% |
Analyst targets & ownership
Mean target$26.20
High target$26.20
Low target$26.20
Implied upside34.02%
Analyst count1
ConsensusBUY
Strong buy / Buy2 / 0
Hold0
Sell / Strong sell0 / 0
Held by insiders24.02%
Held by institutions11.40%
Institutions holding74
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
20.33
-3.84% from price
SMA 20
21.53
-9.23% from price
SMA 50
21.33
-8.41% from price
SMA 100
21.55
-9.30% from price
SMA 200
21.66
-9.79% from price
EMA 12
20.48
-4.55% from price
EMA 26
21.14
-7.51% from price
EMA 50
21.39
-8.60% from price
RSI (14)
32.5
Neutral
MACD (12,26,9)
-0.66
Hist -0.29
ATR (14)
0.61
3.11% of price
Realised vol 30D
39.1%
Annualised
Bollinger upper
24.44
20, 2σ
Bollinger lower
18.61
20, 2σ
50 / 200 cross
Death
21.33 vs 21.66
Trend bias
Below 200
-9.79%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
-0.08
Less volatile than market
Correlation to SPY
-0.04
Largely independent
Realised vol 30D
39.1%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-20.8%
Peak to trough
Max drawdown 5Y
-41.2%
Peak to trough
ATR 14
0.61
3.11% of price
Beta (reported)
-0.01
5Y monthly, from filing
Dividends & splits
Forward rate$1.10 / yr
Forward yield5.63%
5-year avg yield3.63%
Payout ratio80.00%
Ex-dividend dateJun 11, 2026
Next pay date—
Last split15:10
Split dateJul 2, 2014
Headlines
10-man Atletico snatch Villarreal draw as Alvarez returns
AFP · 11m ago
Should You Buy Oracle Stock Before September? The Answer Might Surprise You.
Motley Fool · 13m ago
Fed’s Kashkari says rising Treasury yields not a concern
Investing.com · 16m ago
Bill Ackman's Pershing Square invests $1.1B in fintech giant
TheStreet · 16m ago
Rachel Cruze and George Kamel share the spending 'clues' that reveal if you're broke, average or wealthy
Moneywise · 23m ago
An e.l.f. Beauty Insider Sells 5,718 Shares. Here's What That Means for Investors.
Motley Fool · 26m ago
Dow Jones Futures Due; Nvidia Earnings, Canada Tariffs, Warsh In Focus
Investor's Business Daily · 27m ago
Your Last Chance to Buy Nvidia Stock for Cheap in 2026 May Be Near
Motley Fool · 28m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.